Cyclic nucleotide phosphodiesterases from rat pancreas: differential regulation by a calcium-dependent activator protein [proceedings].

PubWeight™: 0.79‹?›

🔗 View Article (PMID 199510)

Published in Biochem Soc Trans on January 01, 1977

Authors

A Vandermeers, M C Vandermeers, J Rathe, A Delforge, J Christophe

Articles by these authors

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood (1998) 2.66

Secretion of hydrolases by perfused fragments of rat pancreas: effect of calcium. Am J Physiol (1971) 1.62

Calmodulin activation of adenylate cyclase in pancreatic islets. Science (1979) 1.58

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48

Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol (1990) 1.28

In vitro action of bombesin and bombesin-like peptides on amylase secretion, calcium efflux, and adenylate cyclase activity in the rat pancreas: a comparison with other secretagogues. J Clin Invest (1976) 1.25

The stimulus-secretion coupling of glucose-induced insulin release. XLVI. Physiological role of L-glutamine as a fuel for pancreatic islets. Mol Cell Endocrinol (1980) 1.19

Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. Leuk Lymphoma (1999) 1.16

Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes. Br J Pharmacol (1992) 1.14

In vitro interactions of gastrointestinal hormones on cyclic adenosine 3':5'-monophosphate levels and amylase output in the rat pancreas. Gastroenterology (1975) 1.12

Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy (2004) 1.09

Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol Pharmacol (1982) 1.09

Pancreatic secretion of total protein and of three hydrolases collected in healthy subjects via duodenoscopic cannulation. Effects of secretin, pancreozymin, and caerulein. Gastroenterology (1975) 1.05

Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur J Biochem (1992) 1.05

The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors. Peptides (1996) 1.04

Development of high affinity selective VIP1 receptor agonists. Peptides (1997) 1.04

Exocrine pancreas: evidence for topographic partition of secretory function. Science (1975) 1.03

Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985) 1.03

Rat pancreatic hydrolases from birth to weaning and dietary adaptation after weaning. Am J Physiol (1971) 1.02

Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol (1989) 1.01

The stimulus-secretion coupling of amino acid-induced insulin release. Metabolic interaction of L-glutamine and 2-ketoisocaproate in pancreatic islets. Biochim Biophys Acta (1981) 1.00

Carica papaya latex is a rich source of a class II chitinase. Phytochemistry (1997) 0.99

Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985) 0.99

Effect of a high-fat diet on obese-hyperglycaemic and non-obese Bar Harbor mice. Diabetologia (1971) 0.98

Factors regulating biosynthesis, intracellular transport and secretion of amylase and lipase in the rat exocrine pancreas. Horm Metab Res (1971) 0.98

Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone Marrow Transplant (2003) 0.97

The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol (1983) 0.97

Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP- and secretin-like properties (helodermin) from Gila monster venom. FEBS Lett (1984) 0.95

Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev (2005) 0.95

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides (1997) 0.95

Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides (1984) 0.95

Effects of somatostatin on pancreatic exocrine function. Interaction with secretin. Biochem Biophys Res Commun (1975) 0.94

Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett (1990) 0.94

Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol Pharmacol (1986) 0.94

A calcium-dependent protein activator of guanosine 3':5'-monophosphate phosphodiesterase in bovine and rat pancreas. Isolation, properties and levels in vivo. Eur J Biochem (1977) 0.93

Helodermin has a VIP-like effect upon canine blood flow. Peptides (1986) 0.93

In vivo effects of pancreozymin, secretin, vasoactive intestinal polypeptide and pilocarpine on the levels of cyclic AMP and cyclic GMP in the rat pancreas. FEBS Lett (1974) 0.93

Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands. Arch Oral Biol (1985) 0.93

Scorpion venom inhibits carbamylcholine-induced 86rubidium efflux from rat parotid acini. FEBS Lett (1987) 0.93

RDC1 may not be VIP receptor. Trends Pharmacol Sci (1992) 0.92

80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors. FEBS Lett (1988) 0.92

Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom. FEBS Lett (1984) 0.92

[Lipid metabolism in livers of normal mice and obese hyperglycemic mice]. Biochim Biophys Acta (1968) 0.91

Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. Mol Pharmacol (1987) 0.90

Mechanism of 3-phenylpyruvate-induced insulin release. Metabolic aspects. Biochem J (1983) 0.90

Characterization of muscarinic cholinergic receptors on rat pancreatic acini by N-[3H]methylscopolamine binding. Their relationship with calcium 45 efflux and amylase secretion. J Biol Chem (1984) 0.90

The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. Mol Pharmacol (1983) 0.90

Hormone-stimulated GTPase activity in rat pancreatic plasma membranes. FEBS Lett (1979) 0.90

Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. Biochim Biophys Acta (1981) 0.89

Rapid electrotransfer of proteins from polyacrylamide gel to nitrocellulose membrane using surface-conductive glass as anode. Anal Biochem (1985) 0.88

Is helodermin produced by medullary thyroid carcinoma cells and normal C-cells? Immunocytochemical evidence. Regul Pept (1988) 0.88

Proceedings: Biochemical studies on pure pancreatic juice obtained by duodenoscopic cannulation of the pancreatic duct in conscious patients. Gut (1974) 0.88

The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes. FEBS Lett (1991) 0.88

Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. Biochim Biophys Acta (1981) 0.88

7-Day time study of lipid metabolism in normal and obese-hyperglycemic Bar Harbor mice. Qualitative and quantitative aspects. Biochimie (1973) 0.88

Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes. Br J Pharmacol (1989) 0.87

Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties. FEBS Lett (1984) 0.87

Effects of temperature and ethanol on agonist and antagonist binding to rat heart muscarinic receptors in the absence and presence of GTP. Biochem J (1985) 0.87

Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography. Regul Pept (1981) 0.87

The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides (1990) 0.87

VIP activation of rat anterior pituitary adenylate cyclase. FEBS Lett (1979) 0.86

Phosphatidylinositol turnover and calcium movement in the rat pancreas. Am J Physiol (1980) 0.86

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11. Biochem Pharmacol (1997) 0.86

Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors. Life Sci (1987) 0.86

Molecular basis of enzyme secretion by the exocrine pancreas. Adv Cytopharmacol (1974) 0.86

New functionally selective muscarinic agonists. Life Sci (1993) 0.86

Amino acid levels in plasma, liver, muscle, and kidney during and after exercise in fasted and fed rats. Am J Physiol (1971) 0.86

"In vitro" effects of secretin and vasoactive intestinal polypeptide on hydrolase secretion and cylic AMP levels in the pancreas of five animal species. A comparison with caerulein. Gastroenterol Clin Biol (1977) 0.86

Discharge of newly synthesized proteins in pure juice collected from the human pancreas. Indication of more than one pool of intracellular digestive enzymes. Gastroenterology (1977) 0.85

Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochem Pharmacol (1983) 0.85

Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes. Eur J Biochem (1992) 0.85

In vitro inactivation of pancreatic enzymes in washings of the rat small intestine. Am J Physiol (1969) 0.85

Discovery of a potent atrial natriuretic peptide antagonist for ANPA receptors in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol (1992) 0.85

Characterization of VIP-sensitive adenylate cyclase in guinea pig brain. FEBS Lett (1977) 0.85

Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides. Mol Pharmacol (1980) 0.84

Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. Biochem J (1983) 0.84

Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas. Peptides (1986) 0.84

Excessive production of transforming growth factor-beta by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood (1993) 0.84

[Reductive catabolism of uracil in Torulopsis utilis]. Arch Int Physiol Biochim (1964) 0.84

Interaction of calmodulin with a putative calmodulin-binding domain of inositol 1,4,5-triphosphate 3-kinase. Effects of synthetic peptides and site-directed mutagenesis of Trp165. Eur J Biochem (1993) 0.84

Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes. Eur J Pharmacol (1988) 0.84

Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig. Regul Pept (1982) 0.84

Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas. Biochem J (1983) 0.84

Imbalance in production of cytokines by bone marrow stromal cells following cytomegalovirus infection. J Infect Dis (1996) 0.84

Short-term adaptation of pancreatic hydrolases to nutritional and physiological stimuli in adult rats. Biochimie (1971) 0.83

In vitro lipid metabolism in the rat pancreas. III. Effects of carbamylcholine and pancreozymin on the turnover of phosphatidylinositols, 1,2-diacylglycerols and phosphatidylcholines. Biochim Biophys Acta (1979) 0.83

Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum). Eur J Biochem (1987) 0.83